United Kingdom Real World Evidence Solutions Market Insights, Industry Trend, Forecasts to 2035

The real-world evidence (RWE) solutions market in the UK is a growing component of the broader healthcare and life sciences industry. The RWE solutions market consists of the collection of real-world data, real-world evidence analytics platforms, real-world evidence evidence generation services and solutions for post-market monitoring of medical products and services, all of these are enabled by electronic health records, clinical registries, claims data and patient-reported outcomes. RWE solutions can now be used for researching many aspects of pharmaceutical and medical device development, and the digital health ecosystem in supporting regulatory approvals, the assessment of health technology and the development of value-based models for the delivery of healthcare. The RWE Solutions market continues to grow in the UK and is driven by increases in the number of older people, the increase in the prevalence of chronic diseases, and an increased demand for low-cost outcomes of services being provided by NHS England. Strong data assets created by the NHS, pressure to optimise clinical pathways, and the shortening of timeframes to market are also contributing to increased adoption of RWE Solutions.

The UK government, through the MHRA, launched the Real-World Evidence Scientific Dialogue Programme to support innovators via confidential regulatory engagement. The pilot provides guidance on RWE generation and includes MHRA–NICE “safe harbour” workshops, aligning regulatory and health technology assessment expectations while strengthening the UK real world evidence ecosystem.